NANO-X IMAGING LTD
NNOXNASDAQTrading Snapshot
- Day Range
- $0.22 β $0.24
- 52-Week Range
- $0.21 β $4.71
- Volume (shares)
- 11,052
- Avg Volume (shares)
- β
- Shares Outstanding
- 78.7M
- Next Earnings
- 2026-11-25
Fundamentals Snapshot
- Annual Revenue
- $13M
- Last Q Revenue
- $4M
- P/E Ratio
- -0.1
- P/S Ratio
- 1.1x
- EPS (TTM)
- $-1.67
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +11.5%
NANO-X IMAGING LTD
NNOXAbout NANO-X IMAGING LTD
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

Nanox to Showcase Its Innovative Technology and Advances Across Nanox.ARC X and Nanox.AI at RSNA 2026
PETACH TIKVA, Israel, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (βNanoxβ or the βCompanyβ, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will showcase technologies de

Nanox to Report Third Quarter 2026 Financial Results on November 25, 2026
PETACH TIKVA,Β Israel, Nov. 16, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced that it will report its financial re

Nanox Announces Distribution Agreement with Medworks for Nanox.AI in Greece
Building on Nanox.AI's existing deployment in Athens, the agreement supports commercial expansion in Greece throughΒ Medworks ' established market presence.

Nanox.AI Advances Commercial Collaboration with Dosy Health to Bring AI Cardiac Solution to Thailand
Collaboration builds onΒ Dosy Health's established relationships with Mahidol University, Thammasat University and hospitals within the BDMS network, supporting planned distribution and commercialization in Thailand PETA

Nanox Announces That Board Has Approved Cost Reduction and Operational Efficiency Measures
The Board approved plan target s a 25%β30% reduction in annualized operating expenses, compared to annualized 2026 GAAP and non-GAAP operating expenses, once fully implemented, expected by the end of Q 1 202 7 Cost reduc

USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows
PETACH TIKVA, Israel, Nov. 9, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (βNanoxβ or the βCompanyβ, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its wholly owned subsidiary, USA